Drugs / Quadrivalent HPV vaccine
Quadrivalent HPV vaccine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT04096911 | Jul 2019 → Mar 2021 | cervical cancer | Buhai Wang | Unknown | No outcome recorded |
| Phase 2 | NCT01492582 | Jul 2012 → Feb 2019 | — | University of Alabama at Birmingham | Completed | Mixed |
| Phase 2 | NCT00604175 | Feb 2008 → Jan 2012 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 32 trials · 1 missed | ||||||
| Phase 3 | NCT02009800 | Nov 2013 → Dec 2021 | human papilloma virus infection | CHU de Quebec-Universite Laval | Completed | No outcome recorded |
| Phase 3 | NCT01461096 | Mar 2012 → Dec 2015 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02750202 Comparator | Jul 2018 → Jul 2025 | anogenital human papillomavirus infection | University of Pretoria | Completed | No outcome recorded |
Press releases naming this drug 22 releases
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent HPV vaccine | “Participants received three intramuscular doses of either quadrivalent HPV vaccine (HPV4; enrolments on or before March 1, 2016) or nonavalent HPV vaccine (HPV9; enrolments...” PMID 34767765 ↗ Nov 2021 |
| Known as | 4vHPV | “There are no randomized studies comparing the long-term effectiveness of a 2-dose schedule (administered at 0 and 6 months) of quadrivalent human papillomavirus vaccine (4vHPV)...” PMID 40627355 ↗ Jul 2025 |
| Known as | Gardasil | “Food and Drug Administration (FDA)-approved quadrivalent HPV vaccine, Gardasil, at preventing anal HPV infection” NCT01461096 ↗ |
| Known as | HPV4 | “Participants received three intramuscular doses of either quadrivalent HPV vaccine (HPV4; enrolments on or before March 1, 2016) or nonavalent HPV vaccine (HPV9; enrolments...” PMID 34767765 ↗ Nov 2021 |
| Modality | Vaccine | “Quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine.” NCT00604175 ↗ |
| Route | Intramuscular | “via intramuscular injection” NCT00604175 ↗ |